Delivery Order SPE2DB22D2108-SPE2DB25FU3BK

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,186.98 firm fixed-price delivery order covers the supply of Pioglitazone HCL 15 mg tablets. The contract has a period of performance through November 14, 2024 and was awarded on November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,899.44 Firm Fixed Price Delivery Order contract is for the supply of 4566383424 PIOGLITAZONE HCL 30 MG TABLET 500S to support military healthcare programs. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. There is no set-aside designation, indicating open...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 4,564,135,046 units of the pharmaceutical product Pioglitazone HCL 30 mg tablets. The award is valued at $3,561.31 and has a period of performance through April 2, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,074.90, is for the delivery of Pioglitazone HCL 45 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pioglitazone HCL 45 mg tablets. The delivery order, valued at $45,168.68, is a firm fixed-price contract with a completion date of July 24, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award is for the delivery of PIOGLITAZONE HCL 45 MG TABLET 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,038.78, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of March 20, 2023. The contract is not set aside for any specific business designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,511.17 Firm Fixed Price delivery order contract is for the supply of dapagliflozin 10 mg tablets. The award has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,319.07 Firm Fixed Price Delivery Order covers the supply of 4,566,503,726 Glimepiride 2 mg tablets in 100 count bottles. The award has an ultimate completion date of November 21, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.81 firm fixed-price delivery order covers the supply of 4566878224 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has an ultimate completion date of January 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.54 firm-fixed-price delivery order is for the supply of 4,566,150,890 units of the medication Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU3BK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,222.01 Firm Fixed Price Delivery Order contract covers the supply of 4,566,832,860 units of the pharmaceutical drug Pioglitazone HCL 30 mg tablets. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 4/6/25, 12:42 AM